Biotech and Healthcare investors

    363 funds · Updated

    Gatsbie lists 363 Biotech and Healthcare investors (as of 2026-11-18).

    Each one names both biotech & life sciences and healthcare & medtech in its investment focus.

    Most are based in United States (218), United Kingdom (33) and Germany (13); the most common stages are Seed (311), Series A (295) and Pre-Seed (242); the most common kinds of capital are Venture equity (338), Growth equity (113) and Buyout (46).

    Which investors back Biotech and Healthcare startups?

    Gatsbie lists 363 Biotech and Healthcare investors (as of 2026-11-18). Most are in United States (218), United Kingdom (33) and Germany (13). They include Amoon Fund (Ra'anana), Development Partners International (London), Claret Capital Partners (London), Redalpine Venture Partners AG (Zürich), Andreessen Horowitz (Menlo Park) and DCVC (San Francisco). Most deals on record in the last 24 months: Amoon Fund (7 deals), Development Partners International (3 deals) and Claret Capital Partners (2 deals).

    Which family offices invest in Biotech and Healthcare?

    23 of the 363 Biotech and Healthcare investors on Gatsbie are family offices, including Sopris Venture Capital, Alychlo, INTERGROUP PARTNERS AG, TARSADIA INVESTMENTS and BROADVIEW VENTURES.

    Upload your deck to see which of these fit your startup, with a written reason for each.

    20 of 363 funds

    Most active first: deals in the last 24 months, then portfolio companies on record.

    #FundHQStagesPartner emails
    1Amoon FundRa'ananaSeed–Series C+ 15
    2Development Partners InternationalLondonSeed–Series C+ 10
    3Claret Capital PartnersLondonPre-Seed–Series A, Growth 15
    4Redalpine Venture Partners AGZürichPre-Seed–Series A, Series C+ 12
    5Andreessen HorowitzMenlo ParkSeed–Series C+ 38
    6DCVCSan FranciscoPre-Seed–Series B 11
    7HOF CapitalNew YorkPre-Seed–Series B 16
    88VCSan FranciscoSeed–Series C+ 19
    9SV Health InvestorsBostonPre-Seed–Series B 22
    10Aisling CapitalNew YorkSeed–Series C+ 6
    11F-Prime CapitalCambridgePre-Seed–Series B 32
    12Innovation EndeavorsPalo AltoPre-Seed–Series B 9
    13Air Street CapitalLondonPre-Seed–Series B 1
    14BlueYardBerlinPre-Seed–Series A, Series C+ 12
    15General CatalystPraguePre-Seed–Series B 10
    16Avalon VenturesLa JollaPre-Seed–Series B 6
    17Eight Roads VenturesLondonSeed–Series C+ 11
    18Foresite CapitalSan FranciscoPre-Seed–Series B 12
    19Metavallon Venture Capital–Pre-Seed, Seed 8
    20Andera PartnersParisSeed–Series C+ 71

    See more Biotech and Healthcare investors in Investor Discovery

    Other sector pairs

    Biotech and Healthcare investors elsewhere

    Biotech & Life Sciences investors by school

    Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Only funds naming both sectors are listed.

    How to pick an investor search tool